Poly Medicure
Poly Medicure, also known as Poly Medicure Limited, is a leading player in the medical device industry, headquartered in India. Established in 1998, the company has made significant strides in the healthcare sector, particularly in the fields of infusion therapy, vascular access, and wound care. With a strong operational presence across Asia, Europe, and the Americas, Poly Medicure has positioned itself as a trusted provider of innovative medical solutions. The company’s core offerings include a diverse range of products such as intravenous catheters, blood transfusion sets, and surgical sutures, all designed with a focus on safety and efficacy. Poly Medicure is recognised for its commitment to quality and has achieved several certifications, enhancing its reputation in the global market. With a robust portfolio and a dedication to advancing healthcare, Poly Medicure continues to set benchmarks in the medical device industry.
DitchCarbon Score
How does Poly Medicure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Poly Medicure's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Poly Medicure's reported carbon emissions
In 2024, Poly Medicure reported total carbon emissions of approximately 36,820,130 kg CO2e, comprising 2,319,850 kg CO2e from Scope 1 and 33,962,280 kg CO2e from Scope 2 emissions. This reflects a consistent emission pattern from the previous year, 2023, where the company recorded similar figures: 2,319,850 kg CO2e for Scope 1 and 33,962,280 kg CO2e for Scope 2, resulting in total emissions of about 36,282,130 kg CO2e. In 2022, emissions were slightly higher, with Scope 1 at 3,114,940 kg CO2e and Scope 2 at 30,230,620 kg CO2e, leading to total emissions of approximately 33,345,560 kg CO2e. Poly Medicure has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or climate pledges. The company’s emissions data is not cascaded from any parent organisation, indicating that all reported figures are directly from Poly Medicure Limited. The company continues to monitor its emissions intensity, which has shown a slight decrease over the years, with the latest intensity at about 2.7e-09 kg CO2e per rupee of turnover in 2024, down from 3.1e-09 kg CO2e in 2023 and 2.74e-09 kg CO2e in 2022. Overall, while Poly Medicure has made strides in tracking its emissions, further commitments and reduction initiatives would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,114,940 | 0,000,000 | 0,000,000 |
| Scope 2 | 30,230,620 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Poly Medicure is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
